Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
solid tumor
Biotech
Tango axes PRMT5 inhibitor, shifts focus to 2 sibling molecules
Tango has shuffled TNG908 off the dance floor, halting enrollment in a study of the cancer drug candidate to focus on two related molecules.
Nick Paul Taylor
Nov 6, 2024 8:28am
MacroGenics pauses work on ADC pending mature survival data
Nov 6, 2024 4:44am
FDA delays decision on Merus' first-in-class cancer drug
Nov 5, 2024 9:14am
Crescent inks GlycoMimetics merger, securing listing and $200M
Oct 29, 2024 10:20am
Roche MAGE-A4 trial withdrawn after strategic review
Oct 18, 2024 5:30am
Turnstone lays off 60%, shakes up C-suite to stretch out cash
Oct 11, 2024 8:05am
